¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cardiac risk"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® risk factor ÇÑ±Û À§ÇèÀÎÀÚ
¼³¸í   
  ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)°¡ 1977³â ±Ç°í¿¡¼­ ¹æ»ç¼±¹æÈ£ÀÇ ¸ñÀûÀ¸·Î Ã¤ÅÃÇÑ Áö¼ö·Î, ´ÜÀ§¼±·®(1 Sv)´ç È®·üÀû ¿µÇâÀÇ ¹ß»ýÈ®·üÀ» ÃßÁ¤ÇÏ¿© ³ªÅ¸³½ °ÍÀÌ´Ù. »ý½Ä¼± ¼±·®¿¡ ´ëÇÑ À¯ÀüÀû¿µÇâÀÇ ¹ß»ý·ü(4¡¿10£­3/Sv)À̳ª Àû»ö°ñ¼ö¼±·®¿¡ ´ëÇÑ ¹éÇ÷º´ ¹ß»ý·ü(2¡¿10£­3/Sv)µî ¿Ü¿¡ »À, ÇãÆÄ, °©»ó»ù, Á¥»ù, ±âŸ Á¶Á÷ÀÇ À§ÇèÁö¼ö¸¦ ÃøÁ¤ÇÏ¿©, È®·üÀû ¿µÇâÀÇ Àü½Å¿¡ À־ Ä¡»çÀ§ÇèÁö¼öÀÇ Çհ踦 16.5¡¿10£­3/Sv·Î ÇÏ¿´´Ù. ±×ÈÄ ICRP´Â 1990³â ±Ç°í¿¡¼­ ´ë»óÀÌ µÇ´Â Á¶Á÷°ú Àå±â¸¦ Ãß°¡Çϰí, ¼öÄ¡ °³Á¤À» Çϸ鼭 ¸íεµ °¢¸ñÀûÈ®·üÁö¼ö¶ó°íÇÏ¿´´Ù. ÀÌ ±Ç°í¿¡ ÀÇÇϸé, Ä¡»çÀû È®·üÀû ¿µÇâÀÇ È®·üÁö¼öÀÇ ÇÕ°è´Â, ÀϹÝÀο¡ ÀÖ¾î 60.0¡¿10£­3/SvÀÌ´Ù.
¿µ¹® cardiac catheterization ÇÑ±Û ½ÉÀåµµ°ü¼ú
¼³¸í   
  ÆÈ, ´Ù¸® ¶Ç´Â ¸ñÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© ½ÉÀå¿¡ ÀÛÀº Ä«Å×Å͸¦ »ðÀÔÇϴ ¹ý. Ç÷¾×Ç¥º»Ã¤Ãë, ½ÉÀå³»¾ÐÃøÁ¤, ½ÉÀåÀÌ»ó°ËÃâ¿¡ »ç¿ëÇÑ´Ù.
¿µ¹® cardiac scan ÇÑ±Û ½ÉÀ彺ĵ
¼³¸í   
  ½ÉÀåÀÇ ±â´ÉÀ̳ª ÀÌ»óÀ» Æò°¡Çϱâ À§Çؼ­ ¹æ»ç¼±À» ³»´Â ¹°ÁúÀ» Ã¼³»¿¡ Åõ¿©Çϰí À̰ÍÀÌ ³»´Â ¹æ»ç¼±À» ÀÌ¿ëÇÏ¿© ¿µ»óÀ» ¸¸µå´Â ¹æ¹ý.
¿µ¹® cardiac arrest ÇÑ±Û ½ÉÀåÁ¤Áö
¼³¸í   
  ½ÉÀå¹Úµ¿ÀÌ Á¤ÁöÇØ¼­ ½ÉÀåÀÌ Ç÷¾×À» ¹æÃâÇÒ ¼ö ¾ø°ÔµÈ »óŸ¦ ¸»ÇÑ´Ù. ¸ðµç ½É±ÙÀÌ ¼öÃàÇÏÁö ¾Ê°í ½ÉÀåÀÌ ¿ÏÀüÈ÷ Á¤ÁöµÈ »óÅÂÀÇ ¡®½ÉÀåÁ¤Áö¡¯¿Í ½É±ÙÀÌ ºÒ±ÔÄ¢-¹«Áú¼­ÇÑ ¼öÃàÀ» ÇÏÁö¸¸, ¹Úµ¿À¸·Î¼­ Ç÷¾×Àº ¸»ÃʷΠ¹æÃâÇÒ ¼ö ¾ø´Â »óÅÂÀÇ ¡®½É½ÇÀܶ³¸²¡¯ÀÌ ÀÖ´Ù. ÀÓ»óÀûÀ¸·Î´Â ³ú°¡ ºñ°¡¿ªÀûÀΠº¯È­¸¦ ¹Þ´Â ¼øÈ¯±â´É»ó½ÇÀ» ½ÉÀåÁ¤Áö¶ó°í ºÎ¸£°í ÀÖ´Ù.
¿µ¹® cardiac catherization ÇÑ±Û ½ÉÀåÄ«Å×Å׸£¹ý, ½Éµµ°ü¹ý
¼³¸í   
  °¡´À´Ù¶õ °üÀ» Ç÷°üÀ» ÅëÇØ ½ÉÀå¿¡ ³Ö¾î¼­ ¿©·¯ °¡Áö Áø´Ü¿¡ À¯¿ëÇÑ °Ë»ç¸¦ Çϰųª Ä¡·á¸¦ ÇàÇϴ °Í.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • attributable risk
    ±âÀÎÀ§Çèµµ
  • absolute risk model
    Àý´ëÀ§Çè¸ðÇü
  • behavioral risk factor
    ÇൿÀ§Çè¿äÀÎ
  • empiric risk
    °æÇèÀûÀ§Çèµµ
  • high risk group
    °íÀ§Ç豺
  • high risk patient
    °íÀ§ÇèȯÀÚ
  • low risk group
    ÀúÀ§Ç豺
  • physical hazard risk
    ¹°¸®ÀûÀ¯ÇØÀ§Çèµµ
  • population attributable risk
    ¸ðÁý´Ü±âÀÎÀ§Çèµµ
  • relative risk
    »ó´ëÀ§Çèµµ
  • relative risk ratio
    »ó´ëÀ§Çèºñ
  • radiation risk coefficient
    ¹æ»ç¼±À§ÇèÁö¼ö
  • risk
    1. À§Çè 2. À§Çèµµ
  • risk assessment
    À§ÇèµµÆò°¡
  • risk benefit analysis
    À§ÇèÆíÀͺм®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • risk factor
    À§ÇèÀÎÀÚ
  • high risk group
    °íÀ§Ç豺
  • low risk group
    ÀúÀ§Ç豺
  • risk
    À§Çè, À§Çèµµ
  • attributable risk
    ±â¿©À§Çèµµ
  • relative risk
    ºñ±³À§Çèµµ
  • surgical risk
    ¼ö¼úÀ§Çèµµ
  • cardiac arrest
    ½ÉÀåÁ¤Áö
  • cardiac
    ½ÉÀå-, µé¹®-, ½ÉÀ庴ȯÀÚ
  • cardiac catheterization
    ½ÉÀåµµ°ü»ðÀÔ, ½ÉÀåÄ«Å×ÅÍ»ðÀÔ
  • sudden cardiac death
    ±Þ¼º½ÉÀå»ç
  • cardiac index
    ½ÉÀå¹ÚÃâÁö¼ö
  • cardiac minute output
    ºÐ´ç½ÉÀå¹ÚÃâ·®
  • cardiac pump
    ½ÉÀåÆßÇÁ
  • cardiac pacemaker
    ½ÉÀå¹Úµ¿Á¶À²±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute risk
    Àý´ëÀ§Çè, Àý´ëÀ§Çèµµ
  • absolute risk model
    Àý´ëÀ§Çè¸ðÇü
  • acceptable risk
    Çã¿ëÀ§Çè, Çã¿ëÀ§Çèµµ
  • anesthetic risk
    ¸¶ÃëÀ§Çèµµ
  • attributable risk
    ±â¿©À§Çèµµ
  • risk assessment
    À§ÇèµµÆò°¡
  • risk benefit analysis
    À§ÇèÆíÀͺм®
  • behavioral risk factor
    ÇൿÀ§Çè¿äÀÎ
  • benefit/risk ratio
    À¯ÀÍÀ¯ÇغñÀ²
  • radiation risk coefficient
    ¹æ»ç¼±À§ÇèÁö¼ö
  • risk difference
    À§ÇèµµÂ÷ÀÌ
  • explosion risk
    Æø¹ßÀ§Çèµµ
  • relative risk estimation
    »ó´ëÀ§ÇèµµÃßÁ¤
  • risk factor
    À§ÇèÀÎÀÚ
  • high risk group
    °íÀ§Çèµµ±º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute risk
    Àý´ëÀ§Çè
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • acceptable risk
    ¿ëÀÎÀ§Çèµµ, ¼ö¿ëÀ§Çèµµ
  • anesthetic risk
    ¸¶ÃëÀ§Çèµµ.
  • high risk group
    °íÀ§Çèµµ±º(Ë­Ëô̴̬˴).
  • high risk infant
    °íÀ§Ç輺 ¿µ¾Æ.
  • physical hazard =p. risk
    ½ÅüÀû À§Çè (ÊÙËøËôÌ´).
  • physical risk =physical hazard
    ½ÅüÀû À§Çè(µµ)(ËàÌ§ËøËô̴̬)
  • radiation risk
    ¹æ»ç¼±À§ÇØ, ¹æ»ç¼± À§Çè
  • radiation risk coeffecient
    ¹æ»ç¼±À§ÇèÁö¼ö
  • recurrence risk
    Àç¹ßÀ§Çè
  • relative risk
    ºñ±³À§Çèµµ(ËÓË´Ëô̴̬).
  • relative risk
    ºñ±³À§Çèµµ
  • relative risk estimation
    »ó´ë(-Àû) À§Çèµµ ÃßÁ¤(õÏïÒ)
  • ACD=£¾absolute cardiac dullness
    Àý´ë½ÉµÐŹÀ½.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • external cardiac massage ; closed chest cardiac massage
    ÆóÈä½ÉÀ帶»çÁö.¸¶Ãëºñ°³Èä½É(Àå)¸¶»çÁö, ü¿Ü½É¸¶»çÁö.
  • absolute risk
    Àý´ëÀ§Çè
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • acceptable risk
    ¿ëÀÎÀ§Çèµµ, ¼ö¿ëÀ§Çèµµ
  • alcohol, cancer risk
    ¾ËÄÚ¿Ã, ¾Ï À§ÇèÀÎÀÚ(äßêËúÏì×í­), ¾Ï À§Çèµµ(äßêËúÏÓø)
  • anesthetic risk
    ¸¶ÃëÀ§Çèµµ.
  • attributable risk
    ±Í¼ÓÀ§Çèµµ.
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇغñÀ².
  • coronary risk factor
    °ü(»ó)(µ¿¸Æ)ÁúȯÀ§Çè¿äÀÎ.
  • explosion risk
    Æø¹ßÀ§Ç輺.
  • high risk group
    °íÀ§Çèµµ±º(Ë­Ëô̴̬˴).
  • high risk infant
    °íÀ§Ç輺 ¿µ¾Æ.
  • operative risk
    ¼ö¼úÀ§Çèµµ(¼ö¼úÀ§ÇèŹ).
  • physical hazard =p. risk
    ½ÅüÀû À§Çè (ÊÙËøËôÌ´).
  • physical risk =physical hazard
    ½ÅüÀû À§Çè(µµ)(ËàÌ§ËøËô̴̬)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Lymphatic ring of cardiac portion)
    (µé¹®¸²ÇÁÀý°í¸®)
    [¿¾ ¿ë¾î] ºÐ¹®ÀÓÆÄÀý°í¸®
  • Cardiac notch (of left lung)
    (¿ÞÇãÆÄ)½ÉÀåÆÐÀÓ
    [¿¾ ¿ë¾î] ½ÉÀåÀýÈç
  • Thoracic cardiac branches
    °¡½¿½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] Èä½ÉÀåÁö
  • Cardiac orifice
    µé¹®
    [¿¾ ¿ë¾î] ºÐ¹®±¸
  • Cardiac part
    µé¹®ºÎºÐ
    [¿¾ ¿ë¾î] ºÐ¹®
  • Esophageal cardiac gland
    µé¹®½Äµµ»ù
    [¿¾ ¿ë¾î] ºÐ¹®¼±
  • Cardiac notch
    µé¹®ÆÐÀÓ
    [¿¾ ¿ë¾î] ºÐ¹®ÀýÈç
  • Cardiac node
    ½ÉÀå°áÀý
    [¿¾ ¿ë¾î] ½ÉÀå°áÀý
  • Cardiac muscle
    ½ÉÀå±ÙÀ°
    [¿¾ ¿ë¾î] ½É±Ù
  • Cardiac muscle cell
    ½ÉÀå±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ½É±Ù¼¼Æ÷
  • Cardiac muscular tissue
    ½ÉÀå±ÙÀ°Á¶Á÷
    [¿¾ ¿ë¾î] ½É±ÙÁ¶Á÷
  • Cardiac plexus
    ½ÉÀå½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ½ÉÀå½Å°æÃÑ
  • Cardiac ganglia
    ½ÉÀå½Å°æÀý
    [¿¾ ¿ë¾î] ½ÉÀå½Å°æÀý
  • Cardiac jelly
    ½ÉÀ徯±³Áú
    [¿¾ ¿ë¾î] ½É±³Áú
  • Cardiac primordium
    ½ÉÀå¿ø±â
    [¿¾ ¿ë¾î] ½ÉÀå¿ø±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiac genin
    ½É(ãý)°Ô´Ñ
  • cardiac glycoside
    ½É(ãý) ±Û¶óÀÌÄÚ»çÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high risk group
    °íÀ§Çèµµ±º
  • radiation risk
    ¹æ»ç¼±À§ÇØ, ¹æ»ç¼±À§Çè
  • risk
    À§Çè(µµ), À§Ç輺
  • risk factor
    À§Çè¿äÀÎ
  • cardiac
    ½ÉÀåÀÇ, ºÐ¹®ÀÇ
  • cardiac apex
    ½É÷
  • cardiac arrest
    ½ÉÁ¤Áö
  • cardiac catheterization
    ½ÉÄ«Å×Å׸£¹ý, ½ÉµµÀÚ¼ú, ½Éµµ°ü¹ý
  • cardiac cirrhosis
    ¿ïÇ÷¼º°£°æº¯, ½É¼º°£°æº¯Áõ
  • cardiac compensation
    ½ÉÀå´ë»ó
  • cardiac cycle
    ½ÉÀåÁÖ±â
  • cardiac defibrillator
    ½ÉÁ¦¼¼µ¿±â, ½É¼¼µ¿Á¦°Å±â
  • cardiac failure
    ½ÉºÎÀüÁõ
  • cardiac gated MR study
    ½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
  • cardiac gating
    ½ÉÀ嵿±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CRI Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins...
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
HRP high-risk patient; high-risk pregnancy; histidine-rich protein; horseradish peroxidase
RR radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati...
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ARR Absolute risk reduction
aRR Adjusted relative risk
AAR Area at risk
AR At-Risk
ARIC Atherosclerosis Risk In Communities
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • absolute risk
    Àý´ë À§Çè
  • anesthetic risk
    ¸¶Ãë À§Çèµµ
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇØ ºñÀ²
  • coronary risk factor
    °ü»ó µ¿¸Æ Áúȯ À§Çè ¿äÀÎ
  • explosion risk
    Æø¹ß À§Ç輺
  • high risk group
    °íÀ§Çèµµ±º
  • operative risk
    ¼ö¼ú À§Çèµµ
  • risk
    À§Çè, À§Çèµµ, À§Ç輺
  • risk factor
    À§Çè ¿äÀÎ, À§Çè ¿ä¼Ò, À§Çè ÀÎÀÚ
    °³ÀÎÀ̳ª ´Üü°¡ ÁúȯÀ̳ª Àå¾Ö¿¡ °É¸®±â ½±°Ô ÇÏ´Â ¿øÀÎÀÌ µÇ´Â ¿ä¼Ò·Î¼­ ¹Î°¨ÇÑ »ç¶÷µé¿¡¼­ ¹ß»ý ºóµµ¿Í Á¤µµ¸¦ Áõ°¡½ÃŲ´Ù.
  • risk management
    ¼úÀÚÀÇ ¾ÈÀü ¼öÄ¢
  • risk principle
    À§Çèµµ ¿ø¸®
  • advanced cardiac life support
    ÀÌÂ÷ ¼Ò»ý¼ú, ÀÌÂ÷ ½ÉÆó¼Ò»ý¼ú
  • black cardiac syndrome
    Èæ½ÉÀå ÁõÈıº
  • borderline cardiac compensation
    ?
  • cardiac
    ½ÉÀåÀÇ, ½ÉÀ强ÀÇ, ºÐ¹®ÀÇ
    ½ÉÀå°ú °ü·ÃµÈ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
cardiac risk A term to describe overall risk of developing heart disease (blockage of the coronary arteries). Typical risk factors include: diabetes, high blood pressure, prior heart attack, high cholesterol, obesity, smoking and a family history for heart attacks in parents or siblings.
(27 Sep 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absolute risk <statistics> The excess risk due to exposure to a specific hazard (disease, injury, etc.)
(15 Jan 1998)
acceptable risk <statistics> This relates to the potential for suffering disease or injury that will be tolerated by an individual, group, or society in exchange for the benefits of using a substance or process that will cause such disease or injury.
Acceptability of risk depends on scientific data, social, economic, and political factors, and on the perceived benefits arising from a chemical or process that creates the risk in question.
(15 Jan 1998)
attributable risk The rate of a disease or other outcome in exposed individuals that can be attributed to the exposure.
(05 Mar 2000)
recurrence risk In medical genetics, the recurrence risk is the chance that a genetic (inherited) disease present in the family will recur in that family and affect another person (or persons). It is the chance of lightning striking twice (or thrice, etc.).
(12 Dec 1998)
glaucoma, risk factors If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites).
(12 Dec 1998)
relative risk <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased.
(05 Dec 1998)
risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.
(12 Dec 1998)
risk assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.
(12 Dec 1998)
risk benefit An analysis of risk versus benefit is a complex assessment that must be made by a physician prior to the administration of a particular form of drug therapy. Since many medications may have side effects that can be harmful (during the course of treatment), the overall risk of a particular form of drug therapy must be weighed against the overall threat of the untreated disease process (or treatment with an altenative drug).
(27 Sep 1997)
risk factor <statistics> A clearly defined occurrence or characteristic that has been associated with the increased rate of a subsequently occurring disease.
(14 Oct 1997)
risk factors An aspect of personal behaviour or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
(12 Dec 1998)
risk management The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimised. Effective risk management has its greatest benefits in application to insurance in order to avert or minimise financial liability.
(12 Dec 1998)
risk of recurrence In medical genetics, the chance that a genetic (inherited) disease present in a family will recur in that family. The concept in general medicine means the chance that an illness we come back again.
(12 Dec 1998)
risk patient Patient who is at risk, because of his/her behaviour or because of the type of person he/she is.
(18 Nov 1997)
risk reduction Techniques used to reduce your chances of getting a certain cancer. For example: reducing your dietary fat may help prevent breast cancer.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiac
    ½ÉÀåÀÇ
  • cardiac
    ½ÉÀå(º´)ÀÇ;(À§ÀÇ)º»¹®(esophagus)ÀÇ;°­½ÉÁ¦;½ÉÀ庴ȯÀÚ
  • cardiac attest
    ½ÉÀå(¹Úµ¿)Á¤Áö
  • cardiac glycoside
    °­½É ¹è´çü
  • cardiac neurosis
    ½ÉÀå ½Å°æÁõ
  • risk
    À§Çè
  • run a risk
    ¸ðÇèÇÏ´Ù
  • calculated risk
    ¿¹ÃøµÇ´Â À§Çè(½ÇÆÐ)
  • catastrophe risk
    ºñ»ó ÀçÇØ À§Çè
  • country risk
    ±¹°¡º° À§Çèµµ(ÇØ¿Ü À¶ÀÚ¸¦ ÇØÁÙ ¶§ÀÇ À¯ÀÚ ´ë»ó±¹ÀÇ ½Å¿ëµµ)
  • risk
    À§Çè(¼º);¸ðÇè;À§Çè(·ü);º¸Çè±Ý(¾×);ÇǺ¸ÇèÀÚ(¹°);À§Å·ӰÔÇÏ´Ù;¸ðÇèÇÏ´Ù;(À§ÇèµîÀ»)°¢¿ÀÇϰí ÀÖ´Ù;°¨ÇàÇÏ´Ù;°¨È÷...ÇÏ´Ù
  • risk capital
    =VENTURE CAPITAL
  • risk manager
    º¸Çè ´ã´ç ÀÓÁ÷¿ø
  • risk-benefit ratio
    À§Ç輺°ú ¼öÀͼº°úÀÇ ºñÀ²
  • risk-money
    ºÎÁ·±Ý º¸»ó ¼ö´ç(ÀºÇà µî¿¡¼­ Ãâ³³°è¿ø¿¡°Ô ÁÖ´Â)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á